Advertisement
Screener

Vera Therapeutics, Inc. (VERA) Other

Vera Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-02-26: Form 10-K; Item Shares outstanding CommonClassA as of 2026-02-23; As filed 71,355,667.
  • 2026-02-26: Form 10-K; Item Shares outstanding CommonClassB as of 2026-02-23; As filed 0.
  • 2025-02-28: Form 10-K; Item Shares outstanding CommonClassA as of 2025-02-24; As filed 63,748,290.
  • 2025-02-28: Form 10-K; Item Shares outstanding CommonClassB as of 2025-02-28; As filed 0.
FiledFormItemAs filed
2026-02-2610-KShares outstanding CommonClassA as of 2026-02-2371,355,667
2026-02-2610-KShares outstanding CommonClassB as of 2026-02-230
2025-02-2810-KShares outstanding CommonClassA as of 2025-02-2463,748,290
2025-02-2810-KShares outstanding CommonClassB as of 2025-02-280
2025-02-2810-KSmaller reporting companyYes
2024-11-0710-QSmaller reporting companyYes
2024-11-0710-QEmerging growth companyYes
2024-08-0810-QSmaller reporting companyYes
2024-08-0810-QEmerging growth companyYes
2024-05-1010-QSmaller reporting companyYes
2024-05-1010-QEmerging growth companyYes
2024-03-2710-KShares outstanding CommonClassA as of 2024-03-2054,452,029
2024-03-2710-KShares outstanding CommonClassB as of 2024-03-200
2024-03-2710-KSmaller reporting companyYes
2024-03-2710-KEmerging growth companyYes
2024-03-2710-KWell-known seasoned issuerNo
2023-11-0910-QSmaller reporting companyYes
2023-11-0910-QEmerging growth companyYes
2023-08-1010-QSmaller reporting companyYes
2023-08-1010-QEmerging growth companyYes
2023-05-1110-QSmaller reporting companyYes
2023-05-1110-QEmerging growth companyYes
2023-03-2810-KShares outstanding CommonClassA as of 2023-03-2344,261,109
2023-03-2810-KShares outstanding CommonClassB as of 2023-03-230
2023-03-2810-KSmaller reporting companyYes
2023-03-2810-KEmerging growth companyYes
2023-03-2810-KWell-known seasoned issuerNo
2022-11-0910-QSmaller reporting companyYes
2022-11-0910-QEmerging growth companyYes
2022-08-1010-QShares outstanding CommonClassA as of 2022-08-0827,042,276
2022-08-1010-QShares outstanding CommonClassB as of 2022-08-0899,238
2022-08-1010-QSmaller reporting companyYes
2022-08-1010-QEmerging growth companyYes
2022-05-1610-QShares outstanding CommonClassA as of 2022-05-1226,769,188
2022-05-1610-QShares outstanding CommonClassB as of 2022-05-12309,238
2022-05-1610-QSmaller reporting companyYes
2022-05-1610-QEmerging growth companyYes
2022-03-2810-KShares outstanding CommonClassA as of 2022-03-2226,743,289
2022-03-2810-KShares outstanding CommonClassB as of 2022-03-22309,238
2022-03-2810-KSmaller reporting companyYes
2022-03-2810-KEmerging growth companyYes
2022-03-2810-KWell-known seasoned issuerNo
2021-11-1010-QShares outstanding CommonClassA as of 2021-11-0520,968,376
2021-11-1010-QShares outstanding CommonClassB as of 2021-11-05309,238
2021-11-1010-QSmaller reporting companyYes
2021-11-1010-QEmerging growth companyYes
2021-08-1610-QShares outstanding CommonClassA as of 2021-08-1020,968,376
2021-08-1610-QShares outstanding CommonClassB as of 2021-08-10309,238
2021-08-1610-QSmaller reporting companyYes
2021-08-1610-QEmerging growth companyYes
2021-06-2410-QSmaller reporting companyYes
2021-06-2410-QEmerging growth companyYes
2021-06-2410-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
uniQure N.V. (QURE)$2.416B-4.93
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34